Latest news with #SNSInsider
Yahoo
9 hours ago
- Business
- Yahoo
Single-Cell Sequencing Market to Hit USD 7,420.8 Million by 2032 Due to Rising Demand for Precision Medicine and Advanced Genomics
SNS Insider Reveals U.S. Market Dominance with a Projected USD 1,925.10 Million by 2032, Backed by Breakthroughs in Oncology and AI-Driven Single-Cell Platforms Austin, June 11, 2025 (GLOBE NEWSWIRE) -- Single-Cell Sequencing Market Size & Growth Analysis According to SNS Insider, the global Single-Cell Sequencing Market was valued at USD 2,109.8 million in 2023 and is projected to reach USD 7,420.8 million by 2032, expanding at a CAGR of 15% over the forecast period from 2024 to 2032. The rising trend in single-cell technology is attributed to the high demand for personalized precision therapies in cancer and immunology studies, as well as the growing relevance of multi-omic strategies to elucidate cellular a Sample Report of Single-Cell Sequencing Market@ Market Overview The global single-cell sequencing market is experiencing remarkable growth on account of the rising applications in the oncology, immunology, neurology, and infectious diseases research sectors. It enables high-resolution molecular profiling at the single-cell level and drives advances in early disease diagnosis, targeted therapy development, and biomarker discovery. Single-cell platforms are increasingly being developed to boost the drug discovery pipelines of pharmaceutical and biotech companies. At the same time, academia and research facilities are using these tools to explore the intricacies of gene expression, epigenetics, and cellular function. The U.S. market alone was estimated to be worth USD 590.15 million in 2023, and that is projected to reach USD 1925.10 million by 2032, attributable to high research funding, dense biotech presence, and rising clinical trial undertaking via single-cell techniques. Due to the rapid adoption of sequencing platforms and data analytics, as well as their application in genomics through the integration of AI, North America is expected to remain a leading center for single-cell innovation throughout the forecast period. Major Players Analysis Listed in this Report are: Illumina Inc. Thermo Fisher Scientific Inc. 10x Genomics Inc. Becton Dickinson and Company (BD Biosciences) Fluidigm Corporation (now Standard BioTools) Agilent Technologies PerkinElmer Inc. Pacific Biosciences (PacBio) Takara Bio Inc. Bio-Rad Laboratories Inc. QIAGEN N.V. Merck KGaA (MilliporeSigma) Sony Biotechnology Dolomite Bio Oxford Nanopore Technologies GenScript Biotech Mission Bio Roche Sequencing and Life Science Sartorius AG Bruker Corporation Single-Cell Sequencing Market Report Scope Report Attributes Details Market Size in 2023 USD 2,109.8 Million Market Size by 2032 USD 7,420.8 Million CAGR (2024–2032) 15% U.S. Market 2023 USD 590.15 Million U.S. Forecast by 2032 USD 1,925.10 Million Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Technology Next Generation Sequencing (NGS) was the largest technology segment in the market with a revenue share of 45% in 2023. Whole-genome/exome NGS remains the gold standard for high-throughput genomic investigation, despite the trade-off between accuracy and scalability. Its popularity can be largely ascribed to the wide utilization in both academic and clinical research and the ongoing developments in sequencing chemistry and automation. The single-molecule real-time sequencing segment, however, is experiencing the highest rate of growth due to its capabilities to determine epigenetic modifications and its long-read feature that is essential for complex genome mapping and structural variance studies. By Application The application segment of the market was led by cancer research in 2023, accounting for 36% of the market. This dominance is due to single-cell sequencing being increasingly employed to characterize tumor microenvironments, intratumoral heterogeneity, and immune response (all of which are important to immuno-oncology and precision oncology). Drug discovery and development is the most rapidly progressing segment, as pharmaceutical companies increasingly use single-cell analysis for target discovery, compound screening, and toxicity analysis, it speeds up R&D and improves clinical results. By End User In 2023, academic and research institutions held the largest share of 74%. They are a natural choice due to substantial global funding for genomics, strong collaborations with technology vendors, and the increasing tendency to publish high-impact single-cell research in academic journals. The biotechnology and pharmaceutical companies segment, however, is expanding at the highest CAGR as single-cell platforms become more common for use in translational research, companion diagnostics, and therapeutic development. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Single-Cell Sequencing Market Segmentation By Technology Next-Generation Sequencing (NGS)-dominating Polymerase Chain Reaction (PCR) Mass Spectrometry Microarray Other Technologies By Workflow Single-Cell Isolation Sample Preparation Genomic Analysis By Application Cancer Research-dominating Immunology Research Neurobiology Research Stem Cell Research Drug Discovery and Development-fastest growing Other Applications By End User Academic and Research Laboratories-dominating Biotechnology and Pharmaceutical Companies Hospitals and Diagnostic Laboratories Other End Users Regional Analysis North America holds the largest share of the single-cell sequencing market, accounting for 37%, primarily due to the presence of key market players, advanced healthcare infrastructure, and high adoption of genomic technologies. The region's strong research and development investments further reinforce its market dominance. Europe also maintains a significant position, supported by robust healthcare systems and substantial funding for scientific research. Meanwhile, the Asia-Pacific region is witnessing the fastest growth, with a CAGR of 20.16%, driven by increasing investments in healthcare and genomics, the expansion of academic and research institutions, and a growing focus on personalized medicine. Countries like China and India are playing a crucial role in this growth, supported by proactive government initiatives and international collaborations. Recent Developments In April 2024, 10x Genomics introduced a new kit for their Chromium X platform, expanding throughput options for cost-efficient single-cell transcriptomics. In January 2024, Parse released a single-cell kit that allows simultaneous TCR profiling and gene expression from the same cells. In November 2023, Mission Bio introduced updates to its Tapestri platform for simultaneous DNA and protein analysis at the single-cell level. Buy a Single-User PDF of Single-Cell Sequencing Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Single-Cell Sequencing Market by Technology 8. Single-Cell Sequencing Market by Workflow 9. Single-Cell Sequencing Market by Application 10. Single-Cell Sequencing Market by End User 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
9 hours ago
- Business
- Yahoo
MulteFire Market to USD 19.6 Billion by 2032, Owing to Rising Demand for High-Capacity Private LTE Networks
The surging need for unlicensed spectrum-based LTE networks to support enterprise-grade connectivity is propelling MulteFire market growth. Austin, June 11, 2025 (GLOBE NEWSWIRE) -- According to the SNS Insider report, the MulteFire Market size was valued at USD 1.6 billion in 2023 and is projected to reach USD 19.6 billion by 2032, expanding at a robust CAGR of 31.69% from 2024 to 2032. In the U.S., the MulteFire market was valued at approximately USD 9.85 billion in 2023 and is projected to reach around USD 61.4 billion by 2032, growing at a CAGR of 22.1% during 2024–2032. Growth is driven by strong demand for private LTE in smart manufacturing, logistics, and enterprise IT networks. Government-backed spectrum liberalization and early 5G deployment further accelerate MulteFire adoption PDF Sample of MulteFire Market @ Key Players: Nokia Corporation Qualcomm Incorporated Huawei Technologies Co., Ltd. Ericsson Samsung Electronics Co., Ltd. Intel Corporation Altiostar (a Rakuten Symphony company) Cisco Systems, Inc. CommScope Inc. Sercomm Corporation Airspan Networks Inc. ZTE Corporation Ltd. (Mavenir) NEC Corporation Casa Systems Inc. MulteFire Market Report Scope: Report Attributes Details Market Size in 2023 USD 1.6 Billion Market Size by 2032 USD 19.6 billion CAGR CAGR of 31.69% From 2024 to 2032 Base Year 2023 Forecast Period 2024-2032 Historical Data 2020-2022 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Drivers • Rising demand for private wireless networks is boosting MulteFire adoption in industrial sectors. If You Need Any Customization on MulteFire Market Report, Inquire Now @ By Equipment Type: Small Cells Dominate, Controllers to Register Fastest CAGR The Small Cells segment in 2023 and held the largest share of more than 48% of revenue, owing to their wide deployment in the enterprise environment to create private LTE networks, which is highly sought after by companies for being cost-effective, high-capacity, and scalable. Furthermore, companies need dense connectivity support across a range of indoor and outdoor settings. The digital transformation, accompanied by increasing uptake of small cells, is likely to facilitate easy installation and capacity enhancement. The Controllers segment is anticipated to grow at the fastest CAGR as there will be increasing demand for several network management and control, along with security layers for private LTE deployment. Further, only by 2032 will such controllers become indispensable for integrating AI, as well as analytics, into network infrastructure. By End-User: Commercial & Institutional Buildings Lead, Healthcare to Grow Fastest The Commercial & Institutional Buildings segment dominated the market and accounted for 39% of revenue share in 2023, accounting for the majority of the market share, as these places were the early adopters of the MulteFire technology owing to its advantages in security, communication, and facility management. Enterprises and institutions are demanding private LTE networks due to their increased control, operational excellence, and data safety. The Healthcare segment is expected to witness the fastest growth rate as wireless communication is used to access telemedicine, patient monitoring facilities, and medical IoT. MulteFire allows hospitals and clinics to provide patient care and data integration between devices while ensuring privacy and following regulations. By Region: North America Dominates, Asia-Pacific Growing Fastest North America holds the largest share of the global MulteFire Market in 2023, due to the region's strong infrastructure and the early adoption of private LTE networks. In addition, major investments in smart cities and industrial automation, and the presence of large tech companies. Asia-Pacific also registers high growth through the fastest CAGR during the forecast period. Moreover, the rapid pace of urbanization, growing industrial bases in China, India, and other countries, and the government's focus on digitization also increase the implementation opportunities across the region. The adoption by various small and medium enterprises is seen to increase as a result of the high affordability of these solutions across North America. Recent Developments in 2024 In March 2024, Nokia launched its next-generation MulteFire small cell solution for industrial IoT applications. In April 2024, Ericsson collaborated with Amazon Web Services (AWS) to integrate MulteFire with cloud-native private network solutions. In May 2024, Qualcomm announced an enhanced MulteFire chipset with increased spectral efficiency and IoT Full Research Report @ About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
11 hours ago
- Business
- Yahoo
Single-Cell Sequencing Market to Hit USD 7,420.8 Million by 2032 Due to Rising Demand for Precision Medicine and Advanced Genomics
SNS Insider Reveals U.S. Market Dominance with a Projected USD 1,925.10 Million by 2032, Backed by Breakthroughs in Oncology and AI-Driven Single-Cell Platforms Austin, June 11, 2025 (GLOBE NEWSWIRE) -- Single-Cell Sequencing Market Size & Growth Analysis According to SNS Insider, the global Single-Cell Sequencing Market was valued at USD 2,109.8 million in 2023 and is projected to reach USD 7,420.8 million by 2032, expanding at a CAGR of 15% over the forecast period from 2024 to 2032. The rising trend in single-cell technology is attributed to the high demand for personalized precision therapies in cancer and immunology studies, as well as the growing relevance of multi-omic strategies to elucidate cellular a Sample Report of Single-Cell Sequencing Market@ Market Overview The global single-cell sequencing market is experiencing remarkable growth on account of the rising applications in the oncology, immunology, neurology, and infectious diseases research sectors. It enables high-resolution molecular profiling at the single-cell level and drives advances in early disease diagnosis, targeted therapy development, and biomarker discovery. Single-cell platforms are increasingly being developed to boost the drug discovery pipelines of pharmaceutical and biotech companies. At the same time, academia and research facilities are using these tools to explore the intricacies of gene expression, epigenetics, and cellular function. The U.S. market alone was estimated to be worth USD 590.15 million in 2023, and that is projected to reach USD 1925.10 million by 2032, attributable to high research funding, dense biotech presence, and rising clinical trial undertaking via single-cell techniques. Due to the rapid adoption of sequencing platforms and data analytics, as well as their application in genomics through the integration of AI, North America is expected to remain a leading center for single-cell innovation throughout the forecast period. Major Players Analysis Listed in this Report are: Illumina Inc. Thermo Fisher Scientific Inc. 10x Genomics Inc. Becton Dickinson and Company (BD Biosciences) Fluidigm Corporation (now Standard BioTools) Agilent Technologies PerkinElmer Inc. Pacific Biosciences (PacBio) Takara Bio Inc. Bio-Rad Laboratories Inc. QIAGEN N.V. Merck KGaA (MilliporeSigma) Sony Biotechnology Dolomite Bio Oxford Nanopore Technologies GenScript Biotech Mission Bio Roche Sequencing and Life Science Sartorius AG Bruker Corporation Single-Cell Sequencing Market Report Scope Report Attributes Details Market Size in 2023 USD 2,109.8 Million Market Size by 2032 USD 7,420.8 Million CAGR (2024–2032) 15% U.S. Market 2023 USD 590.15 Million U.S. Forecast by 2032 USD 1,925.10 Million Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Technology Next Generation Sequencing (NGS) was the largest technology segment in the market with a revenue share of 45% in 2023. Whole-genome/exome NGS remains the gold standard for high-throughput genomic investigation, despite the trade-off between accuracy and scalability. Its popularity can be largely ascribed to the wide utilization in both academic and clinical research and the ongoing developments in sequencing chemistry and automation. The single-molecule real-time sequencing segment, however, is experiencing the highest rate of growth due to its capabilities to determine epigenetic modifications and its long-read feature that is essential for complex genome mapping and structural variance studies. By Application The application segment of the market was led by cancer research in 2023, accounting for 36% of the market. This dominance is due to single-cell sequencing being increasingly employed to characterize tumor microenvironments, intratumoral heterogeneity, and immune response (all of which are important to immuno-oncology and precision oncology). Drug discovery and development is the most rapidly progressing segment, as pharmaceutical companies increasingly use single-cell analysis for target discovery, compound screening, and toxicity analysis, it speeds up R&D and improves clinical results. By End User In 2023, academic and research institutions held the largest share of 74%. They are a natural choice due to substantial global funding for genomics, strong collaborations with technology vendors, and the increasing tendency to publish high-impact single-cell research in academic journals. The biotechnology and pharmaceutical companies segment, however, is expanding at the highest CAGR as single-cell platforms become more common for use in translational research, companion diagnostics, and therapeutic development. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Single-Cell Sequencing Market Segmentation By Technology Next-Generation Sequencing (NGS)-dominating Polymerase Chain Reaction (PCR) Mass Spectrometry Microarray Other Technologies By Workflow Single-Cell Isolation Sample Preparation Genomic Analysis By Application Cancer Research-dominating Immunology Research Neurobiology Research Stem Cell Research Drug Discovery and Development-fastest growing Other Applications By End User Academic and Research Laboratories-dominating Biotechnology and Pharmaceutical Companies Hospitals and Diagnostic Laboratories Other End Users Regional Analysis North America holds the largest share of the single-cell sequencing market, accounting for 37%, primarily due to the presence of key market players, advanced healthcare infrastructure, and high adoption of genomic technologies. The region's strong research and development investments further reinforce its market dominance. Europe also maintains a significant position, supported by robust healthcare systems and substantial funding for scientific research. Meanwhile, the Asia-Pacific region is witnessing the fastest growth, with a CAGR of 20.16%, driven by increasing investments in healthcare and genomics, the expansion of academic and research institutions, and a growing focus on personalized medicine. Countries like China and India are playing a crucial role in this growth, supported by proactive government initiatives and international collaborations. Recent Developments In April 2024, 10x Genomics introduced a new kit for their Chromium X platform, expanding throughput options for cost-efficient single-cell transcriptomics. In January 2024, Parse released a single-cell kit that allows simultaneous TCR profiling and gene expression from the same cells. In November 2023, Mission Bio introduced updates to its Tapestri platform for simultaneous DNA and protein analysis at the single-cell level. Buy a Single-User PDF of Single-Cell Sequencing Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Single-Cell Sequencing Market by Technology 8. Single-Cell Sequencing Market by Workflow 9. Single-Cell Sequencing Market by Application 10. Single-Cell Sequencing Market by End User 11. Regional Analysis 12. Company Profiles 13. Use Cases and Best Practices 14. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@
Yahoo
12 hours ago
- Business
- Yahoo
Remote Patient Monitoring Market Set to Reach USD 91.95 Billion by 2032, Driven by Rising Chronic Conditions and Technological Advancements
SNS Insider Unveils Strategic Insights into the U.S. Remote Patient Monitoring Market's Steady Expansion—Worth USD 12.76 Billion in 2024—While the North America Commands a 41.2% Share of Global Adoption Through Advanced Digital Health Ecosystem. Austin, June 11, 2025 (GLOBE NEWSWIRE) -- Remote Patient Monitoring Market Size & Growth Analysis: According to SNS Insider, The Remote Patient Monitoring market was estimated at USD 35.47 billion in 2024 and is expected to reach USD 91.95 billion by 2032, at a CAGR of 12.69% during the forecast period of 2024-2032. The market is experiencing rapid expansion, driven by increasing demand for real-time health monitoring systems, particularly among patients managing chronic conditions such as cardiovascular disease and diabetes. Technological advancements in wearable devices, along with the integration of AI-based algorithms, are enhancing the accuracy, reliability, and efficiency of remote monitoring a Sample Report of Remote Patient Monitoring Market@ The U.S. RPM market alone was valued at USD 12.76 billion in 2024 and is expected to grow to USD 32.17 billion by 2032, with a projected CAGR of 12.30% during the forecast period. The United States dominates the North American RPM market, supported by a robust healthcare infrastructure, favorable reimbursement policies, and widespread adoption of digital health technologies. RPM usage is accelerating due to federal efforts to reduce dependency on in-person visits and the rising prevalence of chronic conditions. As a result, the U.S. is expected to remain a major growth driver within the region. Major Players Analysis Listed in this Report are: Philips Healthcare Medtronic GE HealthCare Honeywell Life Sciences Abbott Laboratories Boston Scientific Biotronik Omron Healthcare Dexcom ResMed iRhythm Technologies VitalConnect BioTelemetry (a Philips company) Masimo Corporation Welch Allyn (Hill-Rom) Remote Patient Monitoring Market Report Scope Report Attributes Details Market Size in 2024 US$ 35.47 billion Market Size by 2032 US$ 91.95 billion CAGR CAGR of 12.69% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Insights Market by Component, Devices & Software Segment Held the largest Market Portion In the year 2024, the devices & software segment dominated the market with a 56.1% market share, owing to its vital role in the provision of real-time collection, transmission, and analysis of health data. With the emergence of chronic conditions, particularly cardiovascular diseases and diabetes, wearable devices, biosensors, and connected monitoring tools play a huge role in patient care. User-friendly interfaces, mobile integration, and cloud-based platforms have also enhanced the efficiency and scalability of RPM solutions. The Segment of Cardiovascular Diseases Leads the Market by Application In 2024, the remote patient monitoring market was dominated by the cardiovascular diseases segment, due to heart-related diseases are the leading global cause of death, and the constant need for monitoring is essential to proper management of these diseases. RPM solutions use ECG monitors, Blood pressure cuffs, and heart rate trackers to collect real-time data and spot any complications early, reducing hospital admissions By End-User, the Hospitals Segment Dominates the Market In 2024, the hospitals segment accounted for the largest share of the Remote Patient Monitoring market with a 47.5% market share, owing to their higher consideration factor to include Remote Patient Monitoring technologies, and their robust infrastructure and clinical expertise. Hospitals are leading the way in using RPM to manage chronic disease, support post-discharge care, and improve outcomes. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Remote Patient Monitoring Market Segmentation By Component Services Devices & Software By Application Cardiovascular Diseases Respiratory Diseases Diabetes Musculoskeletal Diseases Others By End-User Hospitals Home Healthcare Settings Ambulatory Care Settings Long-Term Care Centers North America Dominated the Market, Asia Pacific Expected to Exhibit the Fastest Growth North America led the global RPM market in 2024, holding a 41.2% market share. This leadership is supported by a mature healthcare system, supportive government policies, and high acceptance of digital health technologies. The presence of major RPM solution providers and a growing elderly population with chronic illnesses further fuels market demand. Meanwhile, the Asia-Pacific region is projected to witness the fastest growth during the forecast period. This growth is driven by increased healthcare digitization, improving internet and telecommunications infrastructure, and rising awareness of remote healthcare services. Countries such as China, Japan, and India are investing heavily in telemedicine to bridge rural healthcare gaps. The surge in chronic diseases and growing popularity of in-home and mobile health platforms are also key contributors to regional market expansion. Buy a Single-User PDF of Remote Patient Monitoring Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 5.1 Chronic Disease Burden & Aging Population (2024) 5.2 Remote Patient Monitoring Adoption Trends by Region (2024) 5.3 Reimbursement Coverage & Healthcare Spending Trends (2024) 5.4 Hospital Readmission Reduction and Cost-Saving Impact (2024) 6. Competitive Landscape 7. Remote Patient Monitoring Market by Component 8. Remote Patient Monitoring Market by Application 9. Remote Patient Monitoring Market by End-User 10. Regional Analysis 11. Company Profiles 12. Use Cases and Best Practices 13. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Business
- Yahoo
Functional Cosmetics Market to Reach USD 5.44 Billion by 2032, Driven by Rising Demand for Natural Ingredients and Regulatory Transparency
SNS Insider Unveils Strategic Insights into the U.S. Functional Cosmetics Market's Robust Growth-Worth USD 965.42 Million in 2024---While North America Dominates 32.7% of Global Market Share During Beauty Innovation Revolution. Austin, June 10, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Functional Cosmetics Market size was valued at USD 3.62 billion in 2024 and is expected to reach USD 5.44 billion by 2032, growing at a CAGR of 5.37% over the forecast period of 2025-2032. Evolving Consumer Preferences and Regulatory Reforms Fuel Growth in Functional Cosmetics with Emphasis on Safety, Transparency, and Natural Actives The functional cosmetic industry is expanding on account of people's favoring multi-tasking beauty products and bioactive agents. Regulations, such as the MoCRA 2022, demand transparency and safety of products, thus conferring trust via costumers. The US had USD 43 billion in cosmetics revenue in 2021 and high daily use. There is also growing consumer awareness of the dangers of chemicals and demand for natural concoctions, with 78 per cent of consumers worried about toxic ingredients. Ingredient suppliers are also following FDA GMP standards and the integrity and innovation of the market is a Sample Report of Functional Cosmetics Market@ The U.S. functional cosmetics market is worth USD 965.42 million in 2024, and will grow at a CAGR of 4.84% in 2025-2032. Growth in the US functional beauty market is being fuelled by demands for MoCRA certification, increasing skin-health consciousness, and a recently found thirst for innovative US companies, such as Beautycounter and Drunk Elephant, where active-rich natural formulas and strict ingredient-transparency criteria are front of mind. Major Players Analysis Listed in this Report are: L'Oréal S.A. The Estée Lauder Companies Inc. Procter & Gamble Co. Unilever PLC Shiseido Company Limited Beiersdorf AG Kenvue Inc. (formerly Johnson & Johnson Consumer) Amorepacific Corporation Kao Corporation Colgate-Palmolive Company Functional Cosmetics Market Report Scope Report Attributes Details Market Size in 2024 US$ 3.62 billion Market Size by 2032 US$ 5.44 billion CAGR CAGR of 5.23% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Type, Natural Ingredients dominated the Functional Cosmetics Market in 2024 with a 53.8% Market Share. The natural-type segment dominated in 2023 as consumers looked for natural plant-based actives such as ceramides and hyaluronic acid instead of synthetic chemical ingredients. The growing influence of the FDA on harmful additives, along with increasing trust in natural ingredients, drove the segment growth, with botanical extracts being increasingly popular for their clinically proven advantages. This convergence of consumer demand and government backing has established natural materials as the key ingredients in functional cosmetics. By Application, Alpha Hydroxy Acids (AHAs) dominated the Functional Cosmetics Market in 2024 with a 22.5% Market Share. In 2023, Alpha Hydroxy Acids (AHAs) dominated the product-type segment with their ability to exfoliate, hydrate, and combat aging. Brands such as The Ordinary and Neutrogena have AHA products, making them more trusted by consumers. Growth has been fueled by endorsements from dermatology associations and rising US product launches. Evidence-led results and a wide range of usage in skin care routines have made AHAs preferred elements in functional cosmetics. By Form, Creams & Lotions dominated the Functional Cosmetics Market in 2024 with a 38.5% Market Share. In 2023, the creams and lotions dominated because of their hydrating feel, quick spreading properties, and ability to target the delivery of multiple actives. Brands such as CeraVe, Olay, and Clinique market products with ceramides and hyaluronic acid tailored to different skin types. Endorsements from dermatology associations and the availability of tele-dermatology kits for particular skin requirements have also added to their ascendance in the functional cosmetics sector. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Functional Cosmetics Market Segmentation By Type Natural Synthetic By Product Type Alpha Hydroxy Acids (AHAs) Polyhydroxy Acids Beta Hydroxy Acid (Salicylic Acid) Hydroquinone Kojic Acid Retinoid L-Ascorbic Acid Others By Form Cream & Lotion Gel Mask Powders Serums By Functionality Conditioning Agents UV Filters Anti-Ageing Agents Skin-Lightening Agents Others By Application Skin Care Hair Care By End-user Male Female By Distribution Channel Online Brand Websites E-Commerce Websites Offline Departmental Stores Drugstores/Pharmacies Specialty Stores By Region, North America dominated the Functional Cosmetics Market in 2024, Holding A 32.7% Market Share. North America dominated the Functional Cosmetics Market in 2023 owing to early regulatory adoption, high skincare spending, and innovation by major players including Estée Lauder and P&G. The efforts to verify ingredients by FDA and GAO built trust and strengthened stakeholders' collaboration among the different agencies, academia, and start-ups, and consequently accelerated the adoption of the new actives. Additionally, North America had robust e-commerce and telehealth platforms that further facilitated access to the products. Recent Development In May 2025, Shin-Etsu Chemical launched four new silicone ingredients to enhance cosmetic texture, hydration, and microplastic-free soft-focus effects. Buy a Single-User PDF of Functional Cosmetics Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Functional Cosmetics Market by Type 8. Functional Cosmetics Market by Product Type 9. Functional Cosmetics Market by Form 10. Functional Cosmetics Market by Functionality 11. Functional Cosmetics Market by Application 12. Functional Cosmetics Market by End-user 13. Functional Cosmetics Market by Distribution Channel 14. Regional Analysis 15. Company Profiles 16. Use Cases and Best Practices 17. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in to access your portfolio
